Respiratory Illness-related Emergency Visits Among Children, COVID-19 and Beyond: Observing a Return to Seasonal...

The COVID-19 pandemic disrupted care-seeking and respiratory disease epidemiology across healthcare settings, notably for emergency department (ED) care. The scope of this disruption and whether patterns of ED visits have returned to predictable seasonal patterns is of interest in planning ED staffing and resource availability for future illness surges, pandemic or not. We evaluated ED visits for acute respiratory illness among children in a large, integrated healthcare delivery system to describe illness and patient characteristics in the years before, during, and after the pandemic peak.

We conducted a cross-sectional study of ED visits among patients 0-17 years of age to the 21 EDs of Kaiser Permanente Northern California, from January 1, 2018-December 31, 2019, pre-pandemic; January 1, 2020-December 31, 2021, pandemic; and January 1, 2022-March 31, 2024, post-vaccine (vaccines for children > 5 years of age approved and available). We electronically extracted eligible ED visits with acute respiratory infection diagnoses and a range of sociodemographic, medical comorbidity, and utilization characteristics.

We observed 151,983 pediatric ED visits with eligible respiratory infection diagnoses, 49,912 (32.8%) visits pre-pandemic, 27,109 (17.8%) visits during the pandemic, and 74,962 (49.3%) visits post-vaccine. Eligible visits dropped every month from 6,361 in February 2020, just prior to the pandemic onset, to their lowest volume (243) in June 2020. In the post-vaccine period, visits peaked at 10,638 in November 2022, the highest of any month during the study period. Sex, race/ethnicity, and tobacco exposure were comparable over time, but the proportion of visits by patients with under-immunized diagnosis trended upward over time. Upper respiratory infection (30% pre-pandemic, 32% pandemic, and 33% post-vaccine periods), asthma (15% pre-pandemic, 12% pandemic, and 12% post-vaccine periods), and cough (9.9% pre-pandemic, 12% pandemic, and 12% post-vaccine periods), were the top three diagnoses across all periods.

In this cross-sectional study of acute respiratory illness-related ED visits in an integrated healthcare system, from 2022 onward seasonal variation in respiratory illness ED visits rebounded, with notable and unseasonal peaks in late 2022. COVID-19 appears to be a minor contributor to ED visits for pediatric respiratory illness. However, an increased overall and seasonal burden of ED visits has implications for surge planning and mitigation, with COVID-19 now being endemic and typical respiratory pathogens having resurfaced.